Vaccine Company Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 21

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $1.55B

Vaccine Company General Information

Description

Developer of vaccine engineering technology designed to advance immunization against infectious diseases. The company offers in vivo nanoparticle platforms, multivalent antigen engineering, and preclinical vaccine candidates, enabling healthcare and biotechnology sectors to support immunization strategies and address unmet medical needs through scalable and research-driven vaccine development processes.

Contact Information

Website
www.vax.co
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 10421 Motor City Drive Westlake
  • Suite 34416
  • Bethesda, MD 20817-9996
  • United States
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Acquirer
Corporate Office
  • 10421 Motor City Drive Westlake
  • Suite 34416
  • Bethesda, MD 20817-9996
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vaccine Company Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 26-May-2026 $1.55B Completed Pre-Clinical Trials
1. Early Stage VC (Series A) 26-Jun-2025 Completed Pre-Clinical Trials
To view Vaccine Company’s complete valuation and funding history, request access »

Vaccine Company Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-2
Series A-1
Series A 20,068,175 $0.000100 6% $2.2 $2.2 1x $2.2 11.81%
To view Vaccine Company’s complete cap table history, request access »

Vaccine Company Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vaccine Company Former Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
ARCH Venture Partners Venture Capital Minority
Global Health Investment Corporation Venture Capital Minority
Lilly Ventures Corporate Venture Capital Minority
Luma Group Accelerator/Incubator Minority
Pfizer Ventures Corporate Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Vaccine Company FAQs

  • When was Vaccine Company founded?

    Vaccine Company was founded in 2022.

  • Where is Vaccine Company headquartered?

    Vaccine Company is headquartered in Bethesda, MD.

  • What is the size of Vaccine Company?

    Vaccine Company has 21 total employees.

  • What industry is Vaccine Company in?

    Vaccine Company’s primary industry is Biotechnology.

  • Is Vaccine Company a private or public company?

    Vaccine Company is a Private company.

  • What is the current valuation of Vaccine Company?

    The current valuation of Vaccine Company is .

  • What is Vaccine Company’s current revenue?

    The current revenue for Vaccine Company is .

  • How much funding has Vaccine Company raised over time?

    Vaccine Company has raised $132M.

  • Who are Vaccine Company’s investors?

    ARCH Venture Partners, Global Health Investment Corporation, Lilly Ventures, Luma Group, and Pfizer Ventures are 5 of 6 investors who have invested in Vaccine Company.

  • When was Vaccine Company acquired?

    Vaccine Company was acquired on 26-May-2026.

  • Who acquired Vaccine Company?

    Vaccine Company was acquired by Lilly USA.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process